Amgen and MBC Biolabs announce winners of the Amgen Golden Ticket

Amgen (NASDAQ:AMGN) and MBC BioLabs (formerly QB3@953) announced that Delve Therapeutics and Mitokinin have won the Amgen Golden Ticket at MBC BioLabs. Each company receives one year of lab bench space and access to core facilities at the MBC BioLabs life sciences incubator, as well as connections to Amgen's scientific and business leaders to help advance its scientific programs.

Source: World Pharma News - July 12, 2018 Category: Pharmaceuticals Tags: Featured Amgen Business and Industry Source Type: news